Additionally, a notable correlation exists between the expression level of PD-L1 and the individualized treatment regimen, as demonstrated by the mitochondrial pyruvate carrier 3 (MPC3) energy type in the treatment of esophageal squamous cell carcinoma (ESCC) (Wang Z. et al., 2024). Here, CD274 is linked to esophageal squamous cell carcinoma.